Amylyx Pharmaceuticals, Inc. Share Price

Amylyx Pharmaceuticals, Inc. Share Price

NASDAQ: AMLX | Mid Cap
$28.86
+$0.19 (0.66%) Last updated on 31 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Amylyx Pharmaceuticals, Inc. Stock Performance

Open
$28.29
Prev. Close
$28.67
Circuit Range
N/A
Day Range
$28.00 - $29.06
Year Range
$10.85 - $40.42
Volume
66,105
Average Traded
$28.67

Amylyx Pharmaceuticals, Inc. Share Price Today

As of 31 October 2026, Amylyx Pharmaceuticals, Inc.'s share price is $28.86. The stock opened at $28.29, compared to its previous close of $28.67. During today's trading session, Amylyx Pharmaceuticals, Inc.'s share price traded between $28.00 and $29.06, with an average price of $28.53. Over the past 52 weeks, the stock has recorded a high of $40.42 and a low of $10.85. In terms of performance, Amylyx Pharmaceuticals, Inc.'s share price has risen by 80.49% over the last six months and is up 107.40% on a year-on-year basis.

Amylyx Pharmaceuticals, Inc. Share Price Chart

Line chart of the Amylyx Pharmaceuticals, Inc. price trend over the selected period. The price rose overall, ranging from 28.00 to 29.06, ending at 28.85.
$28.00$29.06
L
Show Current Price
H

Amylyx Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Market Cap
$2.73B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.21
Revenue (TTM)
$0.00
Return On Equity (TTM)
-63.59%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-26.26%

Amylyx Pharmaceuticals, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$34.39-$33.00-$41.28-$43.42
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A4.04%-25.09%-5.18%

Amylyx Pharmaceuticals, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$22.23$380.79$87.37$0.00
Net Profit-$198.38$49.27-$301.74-$144.74
Net Profit Margin-892.40%12.94%-345.36%N/A
Income ChangeN/A124.84%-712.42%52.03%

About Amylyx Pharmaceuticals, Inc.

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.

Amylyx Pharmaceuticals, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$28.66
$28.88
-0.98%
Sep 2026
$33.86
$29.16
-21.57%
Aug 2026
$20.00
$37.18
+82.88%
Jul 2026
$17.72
$20.33
+13.16%
Jun 2026
$14.02
$17.96
+25.02%
May 2026
$16.11
$14.37
-10.13%
Apr 2026
$14.02
$15.99
+15.04%
Mar 2026
$15.36
$13.90
-8.49%
Feb 2026
$14.29
$15.19
+6.30%
Jan 2026
$11.98
$14.29
+18.20%
Dec 2025
$14.58
$12.09
-19.24%
Nov 2025
$13.92
$14.97
+7.58%

AMLX Share Price FAQs